Non-thermal plasma induces mitochondria-mediated apoptotic signaling pathway via ROS generation in HeLa cells
1Department of Urology, Sun Yat-Sen University Cancer Centre, Guangzhou 510060, China; Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen 518036, China.
Abstract:
Non-thermal plasma (NTP) has been proposed as a novel therapeutic method for anticancer treatment. Although increasing evidence suggests that NTP selectively induces apoptosis in some types of tumor cells, the molecular mechanisms underlying this phenomenon remain unclear. In this study, we further investigated possible molecular mechanisms for NTP-induced apoptosis of HeLa cells. The results showed that NTP exposure significantly inhibited the growth and viability of HeLa cells. Morphological observation and flow cytometry analysis demonstrated that NTP exposure induced HeLa cell apoptosis. NTP exposure also activated caspase-9 and caspase-3, which subsequently cleaved poly (ADP- ribose) polymerase. Furthermore, NTP exposure suppressed Bcl-2 expression, enhanced Bax expression and translocation to mitochondria, activated mitochondria-mediated apoptotic pathway, followed by the release of cytochrome c. Further studies showed that NTP treatment led to ROS generation, whereas blockade of ROS generation by N-acetyl-l-cysteine (NAC, ROS scavengers) significantly prevented NTP-induced mitochondrial alteration and subsequent apoptosis of HeLa cells via suppressing Bax translocation, cytochrome c and caspase-3 activation. Taken together, our results indicated that NTP exposure induced mitochondria-mediated intrinsic apoptosis of HeLa cells was activated by ROS generation. These findings provide insights to the therapeutic potential and clinical research of NTP as a novel tool in cervical cancer treatment.
Insights
Non-thermal plasma (NTP) induces cancer cell death by activating the mitochondria-mediated apoptosis pathway. Reactive oxygen species (ROS) generated by NTP are key mediators of this anticancer effect in HeLa cells.
Area of Science:
- Biomedical Engineering
- Cancer Biology
- Plasma Medicine
Background:
- Non-thermal plasma (NTP) is an emerging therapeutic modality for cancer treatment.
- The precise molecular mechanisms of NTP-induced apoptosis in tumor cells require further elucidation.
Purpose of the Study:
- To investigate the molecular mechanisms of NTP-induced apoptosis in HeLa cells.
- To determine the role of reactive oxygen species (ROS) in NTP-mediated anticancer effects.
Main Methods:
- HeLa cells were exposed to NTP.
- Cell viability, apoptosis, caspase activation, and mitochondrial pathway markers were assessed.
- ROS generation was measured, and the effect of ROS scavengers (NAC) was evaluated.
Main Results:
- NTP significantly inhibited HeLa cell growth and induced apoptosis.
- NTP activated caspase-9, caspase-3, and PARP cleavage, indicating caspase-dependent apoptosis.
- NTP suppressed Bcl-2, enhanced Bax expression and mitochondrial translocation, leading to cytochrome c release.
- NTP-induced ROS generation was crucial for mitochondrial pathway activation and apoptosis, as NAC treatment abrogated these effects.
Conclusions:
- NTP induces mitochondria-mediated intrinsic apoptosis in HeLa cells, primarily through ROS generation.
- These findings support the potential of NTP as a novel therapeutic strategy for cervical cancer.
More Related Videos
13:20Detection of Mitochondria Membrane Potential to Study CLIC4 Knockdown-induced HN4 Cell Apoptosis In Vitro
Published on: July 17, 2018
06:57Author Spotlight: Fluorescence-Based Quantification of Mitochondrial Membrane Potential and Superoxide Levels Using Live Imaging in HeLa Cells
Published on: May 12, 2023
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Apoptosis
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
